In Practice Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,060
- 试验地点
- 1
- 主要终点
- The number of patients achieving the BP<130/80 mmHg
研究概览
简要总结
Multi-centre survey of type 2 diabetic patients who are currently on anti-hypertensive treatment. Data collection for each patient will take place at one visit. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP<130/80 mmHg. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP<130/80 mmHg by treatment groups. To observe the proportion of patients achieving a therapeutic glycemic response defined as HbA1c=<7%. To observe the proportion of patients achieving fasting plasma glucose<110 mg%. To identify factors for not achieving BP<130/80 mmHg. To describe percentage of patients with positive proteinuria (including microalbuminuria) by treatment groups .
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of written informed consent
- •Patient was diagnosed with type 2 diabetes
- •Patient is on antihypertensive treatments for at least 3 months, with the same regimen for a minimum of 4 weeks prior to survey
排除标准
- •Patients are critically ill, had mental health problems or difficulty in communication
- •Patients who are unwilling or unable to provide informed consent
- •Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
结局指标
主要结局
The number of patients achieving the BP<130/80 mmHg
The percentage of patients achieving the BP<130/80 mmHg
次要结局
- The number and percentage of patients achieving the BP<130/80 mmHg by treatment groups
- The number and percentage of patients achieving HbA1c=<7%
- The number and percentage of patients achieving the FPG<110 mg%
- The association between unachievement of BP<130/80 mmHg and other factors (age, gender, CV risk factors, CV and diabetes history, duration of type of treatment...)
- The number and percentage of patients with positive proteinuria by treatment groups